ArticleTransfusion2019
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).
Abstract readConference ProceedingsHistorical Article
In one paragraph
Article in Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Improved allocation strategies for red cell units of blood group O and RhD-negative revealed by current suboptimal utilization.Journal of translational medicine · 2026Article
- The 2024 international survey of platelet products and practice.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2025Article
- Pathogen-reduction technology, good in more than one way for cellular blood components, is replacing irradiation.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2025Review
- Ultraviolet light and riboflavin accelerates red blood cell dysfunction in vitro and in a guinea pig transfusion model.Blood transfusion = Trasfusione del sangue · 2024Article
- Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction.Frontiers in medicine · 2024Review
- Article
- Review
- The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital.Pathogens (Basel, Switzerland) · 2021Article
- Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology.Vox sanguinis · 2021Article
- What has changed after the COVID-19 pandemic in the publication process? A look-back to "Transfusion clinique et biologique".Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2021Article
- Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder.British journal of haematology · 2020Article
- Transfusion medicine: Overtime paradigm changes and emerging paradoxes.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2020Article
- COVID-19 insights from transfusion medicine.British journal of haematology · 2020Review
- How do you… decide which platelet bacterial risk mitigation strategy to select for your hospital-based transfusion service?Transfusion · 2020Article
- Complete Inactivation of Blood Borne PathogenFrontiers in medicine · 2020Article
- Platelets treated with pathogen reduction technology: current status and future direction.F1000Research · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Chintamani AtreyaUS Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Blood Research and Review, Silver Spring, Maryland.ORCID 0000-0001-7393-2157
Simone GlynnNational Heart Lung and Blood Institute, Bethesda, Maryland, USA.
Michael BuschVitalant Research Institute, San Francisco, California.
Steve KleinmanBlood Bank, Yale-New Haven Hospital, New Haven, Connecticut.
Edward SnyderBlood Bank, Yale-New Haven Hospital, New Haven, Connecticut.
Sara RutterDepartment of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut.
James AuBuchonDepartment of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Willy FlegelDepartment of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland.
David ReeveBlood Components, American Red Cross, Rockville, Maryland.
Dana DevineDepartment of Lab Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, Minnesota.
Claudia CohnDepartment of Lab Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, Minnesota.ORCID 0000-0001-9847-0470
Brian CusterVitalant Research Institute, San Francisco, California.
Raymond GoodrichDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado.
Richard J BenjaminCerus Corporation, Concord, California.
Anna RazatosR&D, TerumoBCT, Inc., Lakewood, Colorado.
Jose CancelasHoxworth Blood Center, University of Cincinnati Health, Cincinnati, Ohio.
Stephen WagnerBlood Components, American Red Cross, Rockville, Maryland.
Michelle MacleanThe Robertson Trust Laboratory for Electronic Sterilisation Technologies (ROLEST), University of Strathclyde, Glasgow, Scotland.
Monique GeldermanDepartment of Hematology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Andrew CapU.S. Army Institute of Surgical Research, San Antonio, Texas.
Paul NessBlood Bank, Johns Hopkins Hospital, Baltimore, Maryland.
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MIntramural FDA HHS FD999999NCATS NIH HHS UL1 TR001863
Abstract
PubMed holds no abstract for this paper.
Indexed as
Congresses as TopicMicrobial ViabilityBlood-Borne PathogensBlood SafetyDisease Transmission, InfectiousDisinfectionHistory, 21st CenturyHumansPandemicsTransfusion ReactionUnited StatesUnited States Food and Drug Administration
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.